Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tint Biotech is a biotechnology company focused on transforming algae biomass into high-performance industrial ingredients for the food, cosmetic, and nutraceutical sectors. The company utilizes a proprietary biorefinery platform and advanced encapsulation technologies to stabilize sensitive algae-derived molecules, such as astaxanthin and phycocyanin, ensuring they maintain functionality under industrial stressors like heat and pH shifts. By partnering with biomass producers to build localized biorefineries, Tint Biotech aims to scale the production of sustainable, natural ingredients globally. Their current product portfolio includes stabilized antioxidants and barrier-support polysaccharides designed for seamless integration into commercial formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TINT.